Tech Company Financing Transactions

Escient Pharmaceuticals Funding Round

On 9/15/2020, Escient Pharmaceuticals raised $77.5 million in Series B investment from Cowen Capital Partners, Sanofi-Genzyme BioVentures and 5AM Ventures.

Transaction Overview

Announced On
9/15/2020
Transaction Type
Venture Equity
Amount
$77,500,000
Round
Series B
Investors
Proceeds Purpose
Escient will use these proceeds to support clinical development.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10578 Science Center Dr. 250
San Diego, CA 92121
USA
Email Address
Overview
Escient Pharmaceuticals. We are a privately held biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications.
Profile
Escient Pharmaceuticals LinkedIn Company Profile
Social Media
Escient Pharmaceuticals Company Twitter Account
Company News
Escient Pharmaceuticals News
Facebook
Escient Pharmaceuticals on Facebook
YouTube
Escient Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Alain Baron
  Alain Baron LinkedIn Profile  Alain Baron Twitter Account  Alain Baron News  Alain Baron on Facebook
Chief Scientific Officer
Marcus Boehm
  Marcus Boehm LinkedIn Profile  Marcus Boehm Twitter Account  Marcus Boehm News  Marcus Boehm on Facebook
Vice President
Richard Pittner
  Richard Pittner LinkedIn Profile  Richard Pittner Twitter Account  Richard Pittner News  Richard Pittner on Facebook
Vice President
Kristin Taylor
  Kristin Taylor LinkedIn Profile  Kristin Taylor Twitter Account  Kristin Taylor News  Kristin Taylor on Facebook
Vice President
Gregg Timony
  Gregg Timony LinkedIn Profile  Gregg Timony Twitter Account  Gregg Timony News  Gregg Timony on Facebook
VP - Bus. Development
William Hodder
  William Hodder LinkedIn Profile  William Hodder Twitter Account  William Hodder News  William Hodder on Facebook
VP - R & D
Esther Martinborough
  Esther Martinborough LinkedIn Profile  Esther Martinborough Twitter Account  Esther Martinborough News  Esther Martinborough on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/15/2020: Attralus venture capital transaction
Next: 9/15/2020: Spine Align venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary